Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Diagnostic Test for Dementia With Lewy Bodies
Sponsor: CND Life Sciences
Summary
The Syn-D Study will be evaluating α-synuclein in patients with suspected MCI-AD and MCI-DLB. Using a simple diagnostic test will improve clinical accuracy in diagnosing, earlier diagnosis, and distinguish between neurodegenerative diseases.
Key Details
Gender
All
Age Range
50 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
80
Start Date
2022-08-15
Completion Date
2025-10-31
Last Updated
2025-01-15
Healthy Volunteers
No
Interventions
Syn-One Test
CND Life Sciences is expanding the utility of its diagnostic technology, the Syn-One Test, to pathologically distinguish between early DLB and Alzheimer's disease to prevent misdiagnoses and establish the relationship between progression and α-synuclein deposition by measuring α- synuclein accumulation in patient's nerve fibers using a simple skin punch biopsy.
Locations (12)
CND Life Sciences
Scottsdale, Arizona, United States
University of California San Diego
La Jolla, California, United States
CenExel RMCR
Englewood, Colorado, United States
University of Miami
Boca Raton, Florida, United States
Neurology One
Winter Park, Florida, United States
Ochsner Research
New Orleans, Louisiana, United States
Mass General Hospital
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Headlands Research
Plymouth, Massachusetts, United States
University of Michigan
Ann Arbor, Michigan, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
University of Utah
Salt Lake City, Utah, United States